Molecular Imaging in Radiation Oncology (MIRO) Over the last decade Molecular Imaging with Positron Emission Tomography has emerged as a complementary modality to anatomic imaging methods for better staging and treatment response evaluation in clinical oncology. Fluorodeoxyglucose has been recognized as a universal radiopharmaceutical for many solid tumours. Methionine has proven its value for intracranial tumours and other tracers, such as fluoro-choline, are finding their ways to routine clinical practice. Tracers of hypoxia and proliferation are emerging to characterize the tumour biology and potentially influence the treatment choice. And many new tracers are on their way… read more>>>

Deadlines:
late registration: February 17, 2010